Biotechnology research and development laboratories or services · California

Poseida Therapeutics

San Diego, CA · ~318 workers · 2 years of OSHA Injury Tracking Application data.

C
Average Safety Record
0.5
Avg TCR
0.5
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Poseida Therapeutics runs at 108% of its industry's injury rate - about level with the typical Biotechnology research and development laboratories or services workplace, earning a grade C.

Poseida Therapeutics: 0.5 TCR = 108% of Biotechnology research and development laboratories or services BLS 0.5 · 2y Form 300A (see methodology below)

Poseida Therapeutics safety composite

Poseida Therapeutics scores strongest on total case rate (tcr) (safer than 66% of same-industry peers) and weakest on dart rate (safer than 37%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

52/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
C 0.54 per 100 workers

Safer than 66% of industry peers

DART rate
D 0.33 per 100 workers

Safer than 37% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−0.4

2022→2023

Poseida Therapeutics injury rate improved

Poseida Therapeutics's TCR fell 0.4 from 0.8 in 2022 to 0.3 in 2023. Peak filing year was 2022 at 0.8 TCR. In 2023, DART was 0.61× this establishment's average TCR (severity share of cases).

2022=0.8 · 2023=0.3

OSHA ITA Form 300A scorecard

Establishment book 541711 · San Diego, CA ABOVE-IND · MID

Grade C · TCR 0.5 · 108% of ind

  • DART 0.3 DART
  • RANK #13/51
  • PHOTO Sanofi @ 225 2nd Ave
  • BOOK 2y book
  • INJ 3 inj
  • SIZE ~318 FTE

Nearest TCR peer: Sanofi @ 225 2nd Ave (0.0 TCR gap)

Read with this employer → · Industry book → · California employers → · Look up another →

Poseida Therapeutics in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Poseida Therapeutics averages 0.5 TCR (108% of the Biotechnology research and development laboratories or services BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Poseida Therapeutics TCR series: 2022=0.8 · 2023=0.3 · BLS 0.5

Where Poseida Therapeutics falls in its industry

189 Biotechnology research and dev establishments

Safer than 66% of graded establishments in this industry, whose median TCR is 0.8.

More dangerous than peersSafer than peers

Narrower to California alone (the establishments it most directly competes with for workers and contracts): ranked #13 safest of 51 Biotechnology research and dev employers in California.

Poseida Therapeutics (318 employees, TCR 0.5) among 29 same-industry peers, split at the industry median of 296 employees and a TCR of 0.8 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,0005,000 05101520 Average employees Total Case Rate Poseida Therapeutics
Poseida Therapeutics (318 employees, TCR 0.5) among 29 same-industry peers, split at the industry median of 296 employees and a TCR of 0.8

Poseida Therapeutics has more employees than the Biotechnology research and development l median and a lower injury rate than the industry's median TCR of 0.8. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2023 0.3 0.3 1 0 0
2022 0.8 0.4 2 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

541711 · CA · San Diego

189 Biotechnology research and development laboratories or services employers nationwide with a credible TCR · 51,834 rated employers in California with headcount on file · 1,979 employers in San Diego, CA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Sanofi @ 225 2nd Ave 0.5 TCR
NAICS-TCR AkzoNobel Powder Coatings Inc. Flying Hills R&D Center 0.5 TCR
NAICS-TCR Alcon Research, LLC 0.6 TCR
NAICS-TCR Battelle - Atlantic City Operations 0.6 TCR
STATE-SIZE Grimmius Cattle Company, Inc. - Home Ranch 318 FTE
STATE-SIZE Alston Construction Company, Inc. 318 FTE
STATE-SIZE Doty Bros. Equipment Co. 318 FTE
STATE-SIZE The Dutra Group 318 FTE
CITY-NEAR UC San Diego Health 9,310 FTE
CITY-NEAR General Atomics 8,108 FTE
CITY-NEAR Health Human Services Agency 6,080 FTE
CITY-NEAR National University 4,955 FTE
NAT-TCR Corporate Office 0.5 TCR
NAT-TCR IA Alcoholic Beverages Division 0.5 TCR
NAT-TCR Hunter Prell Company 0.5 TCR
NAT-TCR Ocean Spray Cranberries Inc 0.5 TCR
NAT-SIZE Skanska USA Civil Northeast 318 FTE
NAT-SIZE LSG Sky Chefs - 1692 318 FTE
NAT-SIZE Oldcastle BuildingEnvelope-Tuscaloosa 318 FTE
NAT-SIZE Plant 11/12 318 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2023, 2022. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.